Emcure Pharmaceuticals IPO Review & Recommendations

Emcure Pharma IPO Peer Comparison

Emcure Pharmaceuticals Limited peer comparison with similar listed entities. (As on March 31, 2024)

The financial information for Emcure Pharma is based on the Restated Consolidated Financial Statements as of and for the financial year ended March 31, 2024. The financial information for listed industry peers mentioned above, sourced from the audited financial statements of the respective companies for the financial year ended March 31, 2024, is on a consolidated basis (except for Abbott India Limited, where financial information is available only on a standalone basis) and is submitted to the Stock Exchanges. 

Notes:

1. Basic and Diluted EPS for peers are sourced from the audited financial statements for the relevant year
2. The P/E Ratio has been computed based on the closing market price of equity shares on BSE Limited on June 21, 2024 divided by the Diluted EPS
3. For listed peers, RoNW is computed as profit attributable to company owners divided by Total Equity attributable to the owners of the Company as on March 31, 2024.
4. Net Asset Value ("NAV") is computed as the closing net worth divided by the equity shares outstanding as on March 31, 2024.